We report the case history of a 75-year-old woman with Parkinson's disease who developed severe cognitive problems after deep brain stimulation (DBS) of the bilateral subthalamic nuclei (STN). After a brief cognitive improvement, the patient gradually deteriorated until she developed full-blown dementia. We discuss the case with respect to the cognitive effects of STN DBS and the possible risk factors of dementia after STN DBS surgery.

1st Department of Neurology St Anne's University Hospital Medical School of Masaryk University Pekarska 53 656 91 Brno Czech Republic

Zobrazit více v PubMed

Rajput AH, Voll A, Rajput ML, Robinson CA, Rajput A. Course in parkinson disease subtypes: a 39-year clinicopathologic study. Neurology. 2009;73(3):206–212. PubMed

Marras C, Rochon P, Lang AE. Predicting motor decline and disability in Parkinson disease: a systematic review. Archives of Neurology. 2002;59(11):1724–1728. PubMed

Hilker R, Schweitzer K, Coburger S, et al. Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity. Archives of Neurology. 2005;62(3):378–382. PubMed

Emre M, Aarsland D, Brown R, et al. Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Movement Disorders. 2007;22(12):1689–1707. PubMed

Hely MA, Morris JGL, Reid WGJ, Trafficante R. Sydney Multicenter Study of Parkinson’s disease: non-L-dopa-responsive problems dominate at 15 years. Movement Disorders. 2005;20(2):190–199. PubMed

Buter TC, van den Hout A, Matthews FE, Larsen JP, Brayne C, Aarsland D. Dementia and survival in Parkinson disease: a 12-year population study. Neurology. 2008;70(13):1017–1022. PubMed

Saint-Cyr JA, Trépanier LL, Kumar R, Lozano AM, Lang AE. Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson’s disease. Brain. 2000;123(10):2091–2108. PubMed

Krack P, Batir A, Van Blercom N, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson’s disease. New England Journal of Medicine. 2003;349(20):1925–1934. PubMed

Benabid AL, Chabardes S, Mitrofanis J, Pollak P. Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson’s disease. The Lancet Neurology. 2009;8(1):67–81. PubMed

Umemura A, Jaggi JL, Hurtig HI, et al. Deep brain stimulation for movement disorders: morbidity and mortality in 109 patients. Journal of Neurosurgery. 2003;98(4):779–784. PubMed

Kleiner-Fisman G, Herzog J, Fisman DN, et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Movement Disorders. 2006;21(14, supplement 14):S290–S304. PubMed

Defer GL, Widner H, Marié RM, Rémy P, Levivier M. Core Assessment Program for Surgical Interventional Therapies in Parkinson’s disease (CAPSIT-PD) Movement Disorders. 1999;14(4):572–584. PubMed

Burns A, Lawlor B, Craig S, editors. Assessment Scales in Old Age Psychiatry. 2nd edition. London, UK: Martin Dunitz, Taylor and Francis Group; 2004.

Fahn S, Elston RL, Members of the UPDRS Development Committee . Unified Parkinson‘s Disease Rating Scale. In: Fahn S, Marsden CD, Goldstein M, Calne DB, editors. Recent Developments in Parkinson‘s Disease. Vol. 2. New York, NY, USA: MacMillan; 1987. pp. 153–163.

Balaz M, Srovnalova H, Rektorova I, Rektor I. The effect of cortical repetitive transcranial magnetic stimulation on cognitive event-related potentials recorded in the subthalamic nucleus. Experimental Brain Research. 2010;203(2):317–327. PubMed

Binder DK, Rau GM, Starr PA. Risk factors for hemorrhage during microelectrode-guided deep brain stimulator implantation for movement disorders. Neurosurgery. 2005;56(4):722–728. PubMed

Gorgulho A, De Salles AAF, Frighetto L, Behnke E. Incidence of hemorrhage associated with electrophysiological studies performed using macroelectrodes and microelectrodes in functional neurosurgery. Journal of Neurosurgery. 2005;102(5):888–896. PubMed

Xiaowu H, Xiufeng J, Xiaoping Z, et al. Risks of intracranial hemorrhage in patients with Parkinson’s disease receiving deep brain stimulation and ablation. Parkinsonism and Related Disorders. 2010;16(2):96–100. PubMed

Sansur CA, Frysinger RC, Pouratian N, et al. Incidence of symptomatic hemorrhage after stereotactic electrode placement. Journal of Neurosurgery. 2007;107(5):998–1003. PubMed

Lyons KE, Wilkinson SB, Overman J, Pahwa R. Surgical and hardware complications of subthalamic stimulation: a series of 160 procedures. Neurology. 2004;63(4):612–616. PubMed

Voges J, Hilker R, Bötzel K, et al. Thirty days complication rate following surgery performed for deep-brain-stimulation. Movement Disorders. 2007;22(10):1486–1489. PubMed

Novak KE, Nenonene EK, Vergenz S, et al. Two cases of ischemia associated with subthalamic nucleus stimulator implantation for advanced Parkinson’s disease. Movement Disorders. 2006;21(9):1477–1483. PubMed

Owen AM. Cognitive dysfunction in Parkinson’s disease: the role of frontostriatal circuitry. Neuroscientist. 2004;10(6):525–537. PubMed

Rektorova I, Srovnalova H, Kubikova R, Prasek J. Striatal dopamine transporter imaging correlates with depressive symptoms and Tower of London task performance in Parkinson’s disease. Movement Disorders. 2008;23(11):1580–1587. PubMed

Hariz MI, Fodstad H. Do microelectrode techniques increase accuracy or decrease risks in pallidotomy and deep brain stimulation? A critical review of the literature. Stereotactic and Functional Neurosurgery. 1999;72:157–169. PubMed

Ory-Magne F, Brefel-Courbon C, Simonetta-Moreau M, et al. Does ageing influence deep brain stimulation outcomes in Parkinson’s disease? Movement Disorders. 2007;22(10):1457–1463. PubMed

Parsons TD, Rogers SA, Braaten AJ, Woods SP, Tröster AI. Cognitive sequelae of subthalamic nucleus deep brain stimulation in Parkinson’s disease: a meta-analysis. Lancet Neurology. 2006;5(7):578–588. PubMed

Smeding HMM, Speelman JD, Koning-Haanstra M, et al. Neuropsychological effects of bilateral STN stimulation in Parkinson disease: a controlled study. Neurology. 2006;66(12):1830–1836. PubMed

Voon V, Kubu C, Krack P, Houeto JL, Tröster AI. Deep brain stimulation: neuropsychological and neuropsychiatric issues. Movement Disorders. 2006;21(14, supplement 14):S305–S327. PubMed

Aybek S, Gronchi-Perrin A, Berney A, et al. Long-term cognitive profile and incidence of dementia after STN-DBS in Parkinson’s disease. Movement Disorders. 2007;22(7):974–981. PubMed

Witt K, Daniels C, Reiff J, et al. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson’s disease: a randomised, multicentre study. The Lancet Neurology. 2008;7(7):605–614. PubMed

Telecka S, Balaz M, Rektorova I, Fanfrdlova Z, Rektor I. Rektor I one year after DBS in patients with Parkinson's disease. Ceska a Slovenska Neurologie a Neurochirurgie. 2010;73(1):57–61.

Strafella AP, Dagher A, Sadikot AF. Cerebral blood flow changes induced by subthalamic stimulation in Parkinson’s disease. Neurology. 2003;60(6):1039–1042. PubMed

Campbell MC, Karimi M, Weaver PM, et al. Neural correlates of STN DBS-induced cognitive variability in Parkinson disease. Neuropsychologia. 2008;46(13):3162–3169. PubMed PMC

Hely MA, Reid WGJ, Adena MA, Halliday GM, Morris JGL. The Sydney Multicenter Study of Parkinson’s disease: the inevitability of dementia at 20 years. Movement Disorders. 2008;23(6):837–844. PubMed

Aarsland D, Kurz MW. The epidemiology of dementia associated with parkinson’s disease. Brain Pathology. 2010;20(3):633–639. PubMed PMC

Halliday G, Hely M, Reid W, Morris J. The progression of pathology in longitudinally followed patients with Parkinson’s disease. Acta Neuropathologica. 2008;115(4):409–415. PubMed

Braak H, Rüb U, Del Tredici K. Cognitive decline correlates with neuropathological stage in Parkinson’s disease. Journal of the Neurological Sciences. 2006;248(1-2):255–258. PubMed

Moss J, Ryder T, Aziz TZ, Graeber MB, Bain PG. Electron microscopy of tissue adherent to explanted electrodes in dystonia and Parkinson’s disease. Brain. 2004;127(12):2755–2763. PubMed

Aarsland D, Kvaløy JT, Andersen K, et al. The effect of age of onset of PD on risk of dementia. Journal of Neurology. 2007;254(1):38–45. PubMed

Moro E, Allert N, Eleopra R, Houeto JL, Phan TM, Stoevelaar H. A decision tool to support appropriate referral for deep brain stimulation in Parkinson's disease. Journal of Neurology. 2009;256(1):83–88. PubMed